Business Context and Reporting Period
Company: Lucid Diagnostics Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: October 17, 2023
Event Date: October 17, 2023 (Closing occurred October 18, 2023)
Context: The Company announced the completion of an unregistered sale of equity securities to accredited investors.
Key Financial Metrics
This filing reports a specific capital raise event rather than periodic financial performance. Key metrics include:
- Securities Issued: 5,000 shares of newly designated Series A-1 Convertible Preferred Stock.
- Purchase Price: $1,000 per share.
- Aggregate Gross Proceeds: $5.0 million.
- Initial Conversion Price: $1.2592 per share of Common Stock.
- Revenue, Profit, Cash Flow, Debt, and Margins: The filing text does not provide a clear value for these operational metrics.
Material Changes Versus Prior Period
The filing details a material change in the Company's capital structure through the issuance of a new class of preferred stock:
- New Security Class: Creation of Series A-1 Convertible Preferred Stock, which ranks pari passu with the existing Series A Preferred Stock issued in March 2023 and senior to Common Stock.
- Capitalization: The Company's authorized preferred stock remains up to 20,000,000 shares, with 5,000 shares now designated as Series A-1.
- Registration Rights: Execution of a Registration Rights Agreement requiring the Company to file a registration statement for the resale of Common Stock issuable upon conversion.
Guidance, Outlook, and Terms of the Offering
The filing outlines specific terms governing the new securities rather than providing forward-looking operational guidance:
- Conversion Terms: Convertible at the holder's option after six months (or upon effective registration) or automatically on October 18, 2025.
- Dividend Rights: Holders are entitled to dividends in the form of Common Stock equal to 20% of the shares issuable upon conversion, payable on October 18, 2024, and October 18, 2025.
- Liquidation Preference: In a liquidation event, holders receive the greater of the Stated Value ($1,000) plus accrued dividends, or the amount payable if converted immediately prior to the event.
- Beneficial Ownership Limitation: Conversion and dividend receipt are capped to prevent any holder from beneficially owning more than 4.99% (or 9.99% upon election) of outstanding Common Stock.
- Voting Rights: Holders generally have no voting rights except as required by law.
Important Facts for Investor Verification
- Verify the dilution impact of the 5,000 shares of Series A-1 Preferred Stock converting into Common Stock at the $1.2592 conversion price.
- Confirm the status of the Registration Rights Agreement and the timeline for the filing of the registration statement for resale.
- Assess the impact of the 20% dividend accruals in 2024 and 2025 on future share count and earnings per share.
- Review the "Deemed Liquidation Event" definition in the Certificate of Designation (Exhibit 3.1) to understand potential payout scenarios.
- Check subsequent filings for the actual filing date of the registration statement covering the resale of conversion shares.